ArticleFrontiers in cellular and infection microbiology2024

Role of gut microbiota and metabolomics in the lipid-lowering efficacy of statins among Chinese patients with coronary heart disease and hypercholesterolemia.

Lihua Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.